Please report any side effects to the Yellow Card Scheme, even if they are not listed in the patient information leaflet
Current users are about twice as likely to be obese as those who have never taken injections (71% vs
In the SURMOUNT-5 trial, published in the New England Journal of Medicine, patients receiving tirzepatide had a mean percent decrease in body weight of 20.2%, compared with 13.7% for those receiving semaglutide,over 72 weeks
Most of the patients we see are unaware of the process and come without prescriptions, Sikri said
In New Zealand, Wegovy is only approved for people with: This means people in the healthy BMI range (18.524.9) are not eligible for Wegovy under current guidelines, unless there are other significant medical factors involved
How long does semaglutide last in the fridge